Inclusion on the WHO list puts pressure on governments to make medicines available and on companies to lower prices
South African pharmaceutical company Aspen Pharmacare has set a third-quarter 2026 target for launching generic semaglutide in Canada, positioning the country as a reference market for future expansion into emerging regions
Mar 1, 2026 Why semaglutide stops working for some people You did everything right
This is an average estimate, not a guarantee, and individual clearance may vary based on body size, kidney and liver function, and dosing history
The American Association of Clinical Endocrinology is developing an obesity algorithm to help stratify the risk of obesity and guide treatment decisions based on a holistic assessment of an individuals clinical risk factors, which should be finalized in the next few months, according to Dr